337 related articles for article (PubMed ID: 15156176)
1. Role of RUNX family members in transcriptional repression and gene silencing.
Durst KL; Hiebert SW
Oncogene; 2004 May; 23(24):4220-4. PubMed ID: 15156176
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic gene silencing by Runx proteins.
Taniuchi I; Littman DR
Oncogene; 2004 May; 23(24):4341-5. PubMed ID: 15156191
[TBL] [Abstract][Full Text] [Related]
3. Structure and regulated expression of mammalian RUNX genes.
Levanon D; Groner Y
Oncogene; 2004 May; 23(24):4211-9. PubMed ID: 15156175
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic potential of the RUNX gene family: 'overview'.
Ito Y
Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
[TBL] [Abstract][Full Text] [Related]
5. The Runx genes: lineage-specific oncogenes and tumor suppressors.
Cameron ER; Neil JC
Oncogene; 2004 May; 23(24):4308-14. PubMed ID: 15156187
[TBL] [Abstract][Full Text] [Related]
6. Upstream and downstream targets of RUNX proteins.
Otto F; Lübbert M; Stock M
J Cell Biochem; 2003 May; 89(1):9-18. PubMed ID: 12682904
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
Spender LC; Whiteman HJ; Karstegl CE; Farrell PJ
Oncogene; 2005 Mar; 24(11):1873-81. PubMed ID: 15688019
[TBL] [Abstract][Full Text] [Related]
8. RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription.
Reed-Inderbitzin E; Moreno-Miralles I; Vanden-Eynden SK; Xie J; Lutterbach B; Durst-Goodwin KL; Luce KS; Irvin BJ; Cleary ML; Brandt SJ; Hiebert SW
Oncogene; 2006 Sep; 25(42):5777-86. PubMed ID: 16652147
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor activity of RUNX3.
Bae SC; Choi JK
Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
[TBL] [Abstract][Full Text] [Related]
10. Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins.
Miyazono K; Maeda S; Imamura T
Oncogene; 2004 May; 23(24):4232-7. PubMed ID: 15156178
[TBL] [Abstract][Full Text] [Related]
11. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.
Liu S; Shen T; Huynh L; Klisovic MI; Rush LJ; Ford JL; Yu J; Becknell B; Li Y; Liu C; Vukosavljevic T; Whitman SP; Chang KS; Byrd JC; Perrotti D; Plass C; Marcucci G
Cancer Res; 2005 Feb; 65(4):1277-84. PubMed ID: 15735013
[TBL] [Abstract][Full Text] [Related]
12. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
13. Homologs of RUNX and CBF beta/PEBP2 beta in C. elegans.
Lee J; Ahnn J; Bae SC
Oncogene; 2004 May; 23(24):4346-52. PubMed ID: 15156192
[TBL] [Abstract][Full Text] [Related]
14. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
[TBL] [Abstract][Full Text] [Related]
15. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
Okumura AJ; Peterson LF; Lo MC; Zhang DE
Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
[TBL] [Abstract][Full Text] [Related]
16. Pathways in blood and vessel development revealed through zebrafish genetics.
Crosier PS; Kalev-Zylinska ML; Hall CJ; Flores MV; Horsfield JA; Crosier KE
Int J Dev Biol; 2002; 46(4):493-502. PubMed ID: 12141436
[TBL] [Abstract][Full Text] [Related]
17. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
[TBL] [Abstract][Full Text] [Related]
18. An enigmatic fourth runt domain gene in the fugu genome: ancestral gene loss versus accelerated evolution.
Glusman G; Kaur A; Hood L; Rowen L
BMC Evol Biol; 2004 Nov; 4():43. PubMed ID: 15527507
[TBL] [Abstract][Full Text] [Related]
19. Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes.
Sato T; Ohno S; Hayashi T; Sato C; Kohu K; Satake M; Habu S
Immunity; 2005 Mar; 22(3):317-28. PubMed ID: 15780989
[TBL] [Abstract][Full Text] [Related]
20. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.
Osato M
Oncogene; 2004 May; 23(24):4284-96. PubMed ID: 15156185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
